Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of n-3 Fatty Acid Supplementation on the Metabolic Abnormalities in Children With NAFLD

NCT02201160 is registered in ClinicalTrials.gov with St. Justine's Hospital as lead sponsor.

NCT NCT02201160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02201160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of n-3 Fatty Acid Supplementation on the Metabolic Abnormalities in Children With NAFLD
Lead sponsor
St. Justine's Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2009
Completion date
December 31, 2015
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non alcoholic fatty liver disease (nafld)